|
NUFIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.764600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.216600E-03 |
| Normal-vs-Stage2 |
1.166620E-01 |
| Normal-vs-Stage3 |
2.219800E-01 |
| Normal-vs-Stage4 |
8.220800E-01 |
| Stage1-vs-Stage2 |
8.957400E-01 |
| Stage1-vs-Stage3 |
7.916400E-01 |
| Stage1-vs-Stage4 |
3.899000E-01 |
| Stage2-vs-Stage3 |
7.897200E-01 |
| Stage2-vs-Stage4 |
4.461600E-01 |
| Stage3-vs-Stage4 |
6.095600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.026410E-02 |
| Normal-vs-AfricanAmerican |
1.482090E-02 |
| Normal-vs-Asian |
2.318500E-02 |
| Caucasian-vs-AfricanAmerican |
6.463400E-01 |
| Caucasian-vs-Asian |
5.419600E-01 |
| AfricanAmerican-vs-Asian |
6.208800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.757400E-04 |
| Normal-vs-Female |
5.171000E-01 |
| Male-vs-Female |
3.288000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.857980E-02 |
| Normal-vs-Extreme_Weight |
5.049600E-04 |
| Normal-vs-Obese |
1.933590E-01 |
| Normal-vs-Extreme_Obese |
3.428200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.846000E-01 |
| Normal_Weight-vs-Obese |
3.279200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.913200E-01 |
| Extreme_Weight-vs-Obese |
1.050240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.030400E-01 |
| Obese-vs-Extreme_Obese |
6.747600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.718000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.041200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.829500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.046190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.873600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.676800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.228600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.679000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.169700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.144400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.503300E-03 |
| Normal-VS-Type2 PRCC |
1.046180E-02 |
| Normal-VS-KIRP CIMP |
3.641600E-03 |
| Normal-VS-Unclassified PRCC |
6.433000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.370400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.639800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.587370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.056800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.724560E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.734790E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.51829999999987E-05 |
| Normal-vs-N1 |
5.225000E-01 |
| Normal-vs-N2 |
2.076400E-01 |
| N0-vs-N1 |
1.285670E-02 |
| N0-vs-N2 |
4.957000E-01 |
| N1-vs-N2 |
1.391590E-01 |
|
|
